rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2010-12-20
|
pubmed:abstractText |
Escape mutations in HIV-1 cytotoxic T cell (CTL) epitopes can abrogate recognition by the TCR of HIV-1-specific CD8+ T cells, but may also change interactions with alternative MHC class I receptors. Here, we show that mutational escape in three HLA-A11-, B8- and B7- restricted immunodominant HIV-1 CTL epitopes consistently enhances binding of the respective peptide/MHC class I complex to Immunoglobulin-like transcript 4 (ILT4), an inhibitory myelomonocytic MHC class I receptor expressed on monocytes and dendritic cells. In contrast, mutational escape in an alternative immunodominant HLA-B57-restricted CTL epitope did not affect ILT4-mediated recognition by myelomonocytic cells. This suggests that in addition to abrogating recognition by HIV-1-specific CD8 T cells, mutational escape in some, but not all CTL epitopes may mediate important immunoregulatory effects by increasing binding properties to ILT4, and augmenting ILT4-mediated inhibitory effects of professional antigen-presenting cells.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD14,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD80,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B57 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/LILRB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e15084
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21170342-Antigens, CD14,
pubmed-meshheading:21170342-Antigens, CD80,
pubmed-meshheading:21170342-CD8-Positive T-Lymphocytes,
pubmed-meshheading:21170342-DNA Mutational Analysis,
pubmed-meshheading:21170342-Epitopes,
pubmed-meshheading:21170342-Genes, MHC Class I,
pubmed-meshheading:21170342-HIV-1,
pubmed-meshheading:21170342-HLA-B Antigens,
pubmed-meshheading:21170342-Histocompatibility Antigens Class I,
pubmed-meshheading:21170342-Humans,
pubmed-meshheading:21170342-Membrane Glycoproteins,
pubmed-meshheading:21170342-Monocytes,
pubmed-meshheading:21170342-Mutation,
pubmed-meshheading:21170342-Peptides,
pubmed-meshheading:21170342-Receptors, Immunologic,
pubmed-meshheading:21170342-T-Lymphocytes, Cytotoxic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Mutational escape in HIV-1 CTL epitopes leads to increased binding to inhibitory myelomonocytic MHC class I receptors.
|
pubmed:affiliation |
Ragon Institute of Massachusetts General Hospital, Harvard and MIT, Boston, Massachusetts, United States of America. xyu@partners.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|